G Nagel1, U Wedding, B Röhrig, D Katenkamp. 1. Comprehensive Cancer Center/Field study Breast CAncer, Friedrich-Schiller-University, Jena, Germany. g.nagel@dkfz-heidelberg.de
Abstract
PURPOSE: The aim was to assess the impact of comorbidity on survival of postmenopausal women with breast cancer diagnosis in the period 1995-1997. METHODS: The level of comorbidity was described by the methods suggested by Satariano and Charlson. Cox's proportional hazard models were used to explore the impact of comorbidity on all-cause mortality. RESULTS: After a median follow-up time of 52 months, an increasing level of comorbidity was associated with a higher all-cause mortality. Compared to patients with-out comorbid conditions, the hazard ration of death (HR) was 1.2 (95% CI: 0.8-1.7) for Satariano index 1 and HR 2.3 (95% CI: 1.5-3.5) for Satariano index >or=2, and HR 1.6 and 2.1 for the Charlson comorbidity index, respectively. Independent of comorbidity, the treatment pattern had a strong impact on survival. The level of comorbidity has an influence on the 3-year survival of postmenopausal women with breast cancer. CONCLUSIONS: Long-term follow-up is required to appraise these findings in relation to treatment strategies.
PURPOSE: The aim was to assess the impact of comorbidity on survival of postmenopausal women with breast cancer diagnosis in the period 1995-1997. METHODS: The level of comorbidity was described by the methods suggested by Satariano and Charlson. Cox's proportional hazard models were used to explore the impact of comorbidity on all-cause mortality. RESULTS: After a median follow-up time of 52 months, an increasing level of comorbidity was associated with a higher all-cause mortality. Compared to patients with-out comorbid conditions, the hazard ration of death (HR) was 1.2 (95% CI: 0.8-1.7) for Satariano index 1 and HR 2.3 (95% CI: 1.5-3.5) for Satariano index >or=2, and HR 1.6 and 2.1 for the Charlson comorbidity index, respectively. Independent of comorbidity, the treatment pattern had a strong impact on survival. The level of comorbidity has an influence on the 3-year survival of postmenopausal women with breast cancer. CONCLUSIONS: Long-term follow-up is required to appraise these findings in relation to treatment strategies.
Authors: Timothy L Lash; Soe Soe Thwin; Nicholas J Horton; Edward Guadagnoli; Rebecca A Silliman Journal: Am J Epidemiol Date: 2003-02-01 Impact factor: 4.897
Authors: C J Newschaffer; T L Bush; L E Penberthy; M Bellantoni; K Helzlsour; M Diener-West Journal: J Gerontol A Biol Sci Med Sci Date: 1998-09 Impact factor: 6.053
Authors: Amresh D Hanchate; Kerri M Clough-Gorr; Arlene S Ash; Soe Soe Thwin; Rebecca A Silliman Journal: J Gen Intern Med Date: 2010-06-08 Impact factor: 5.128
Authors: Catherine M Alfano; Juan Peng; Rebecca R Andridge; Monica E Lindgren; Stephen P Povoski; Adele M Lipari; Doreen M Agnese; William B Farrar; Lisa D Yee; William E Carson; Janice K Kiecolt-Glaser Journal: J Clin Oncol Date: 2016-11-28 Impact factor: 44.544
Authors: Jennifer L Patnaik; Tim Byers; Carolyn Diguiseppi; Thomas D Denberg; Dana Dabelea Journal: J Natl Cancer Inst Date: 2011-06-30 Impact factor: 13.506
Authors: Jennifer H Jordan; Soe Soe Thwin; Timothy L Lash; Diana S M Buist; Terry S Field; Reina Haque; Pamala A Pawloski; Hans V Petersen; Marianne N Prout; Virginia P Quinn; Marianne Ulcickas Yood; Rebecca A Silliman; Ann M Geiger Journal: Breast Cancer Res Treat Date: 2014-06-18 Impact factor: 4.872
Authors: Thomas P Ahern; Jaclyn Lf Bosco; Rebecca A Silliman; Marianne Ulcickas Yood; Terry S Field; Feifei Wei; Timothy L Lash Journal: Clin Epidemiol Date: 2009-08-09 Impact factor: 4.790
Authors: Sushma Jonna; Leslie Chiang; Jingxia Liu; Maria B Carroll; Kellie Flood; Tanya M Wildes Journal: Support Care Cancer Date: 2016-07-27 Impact factor: 3.603
Authors: Ruth E Patterson; Shirley W Flatt; Nazmus Saquib; Cheryl L Rock; Bette J Caan; Barbara A Parker; Gail A Laughlin; Kirsten Erickson; Cynthia A Thomson; Wayne A Bardwell; Richard A Hajek; John P Pierce Journal: Breast Cancer Res Treat Date: 2010-01-14 Impact factor: 4.872
Authors: Sarah Nechuta; Wei Lu; Ying Zheng; Hui Cai; Ping-Ping Bao; Kai Gu; Wei Zheng; Xiao Ou Shu Journal: Breast Cancer Res Treat Date: 2013-04-19 Impact factor: 4.872